400-6699-1171000

分析测试百科网 认证会员,请放心拨打!

首页> 产品展示> 化合物 AAK1-IN-4 T61499
普通会员

诚信认证:

工商注册信息已核实!

快速导航
品牌
其他生物化学试剂

化合物 AAK1-IN-4 T61499

英文名称:AAK1-IN-4
品牌 厂商性质 产地 货期
TargetMol 生产商 美国 现货

性能特点

生化试剂,可用于动物细胞实验

在线咨询 询底价
AI问答
配套的仪器设备? 可以搭配的相关耗材试剂?
产品参数
规格 CAS号 价格 操作
100 mg 1815612-79-3 ¥17,500.00 询底价
25 mg 1815612-79-3 ¥10,600.00 询底价
50 mg 1815612-79-3 ¥13,800.00 询底价
产品介绍

Product Introduction
Bioactivity


英文名: AAK1-IN-4

描述: AAK1-IN-4 is a potent and specific inhibitor of adaptor protein-2-associated kinase 1 (AAK1), capable of efficiently penetrating the central nervous system and exhibiting oral bioactivity. It has demonstrated a high degree of selectivity with an AAK1 inhibitory concentration (IC50) of 4.6 nM, a Filt dissociation constant (Ki) of 0.9 nM, and a cellular IC50 of 8.6 nM. AAK1-IN-4 holds promise as a valuable tool in the investigation of neuropathic pain [1].

体外活性: AAK1-IN-4 (compound 43) (0.5 μM, 0-10 min) has good cell potencies of 2.4 in liver microsomes, as well as good metabolic stability (value of 95, 95, 93 for human, rat, and mouse microsomes, respectively) and no issue with CYP inhibitions [1].

体内活性: AAK1-IN-4 (3 mg/kg; p.o; single) can significantly reduce tactile allodynia with close to 80% inhibition of the pain response in the rat CCI-induced pain model [1]. AAK1-IN-4 (3 mg/kg; p.o; 0-7.5 hours) has good spinal cord penetration and spinal-cord-to-plasma-concentration ratios of 8.8 [1]. AAK1-IN-4 (1-10 mg/kg; p.o.; 0-24.5 hours) can significantly reduces mechanical allodynia with over 80% peak inhibition of the pain response achieved at an oral dose of 10 mg/kg, and over 60% peak inhibition of the pain response at 3 mg/kg [1]. Animal Model: Male Sprague-Dawley rats (chronic constriction injury, CCI) [1] Dosage: 3 mg/kg Administration: p.o, 0-7.5 hours Result: Significantly reduced tactile allodynia with close to 80% inhibition of the pain response, as well as showed good spinal cord penetration and spinal-cord-to-plasma-concentration ratios of 8.8. Animal Model: Male Sprague-Dawley rats (STZ-induced diabetic peripheral neuropathic pain, DPNP) [1] Dosage: 1-10 mg/kg Administration: p.o., 0-24.5 hours Result: Significantly reduced mechanical allodynia with over 80% peak inhibition of the pain response achieved at an oral dose of 10 mg/kg, and over 60% peak inhibition of the pain response at 3 mg/kg.

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

化合物 AAK1-IN-4 T61499信息由TargetMol中国为您提供,如您想了解更多关于化合物 AAK1-IN-4 T61499报价、型号、参数等信息,欢迎来电或留言咨询。

注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途

店铺推荐
  • 品牌:TargetMol
    蛋白酶抑制剂 Cocktail (EDTA-Free, 100× in DMSO) C0001

    蛋白酶抑制剂 Cocktail (EDTA-Free, 100× in DMSO) C0001

    询价
  • 品牌:TargetMol
    磷酸酶抑制剂 Cocktail I (100× ddH2O) C0002

    磷酸酶抑制剂 Cocktail I (100× ddH2O) C0002

    询价
  • 品牌:TargetMol
    磷酸酶抑制剂 Cocktail II (100× DMSO) C0003

    磷酸酶抑制剂 Cocktail II (100× DMSO) C0003

    询价
  • 品牌:TargetMol
    磷酸酶抑制剂 Cocktail III (2 Tubes, 100x) C0004

    磷酸酶抑制剂 Cocktail III (2 Tubes, 100x) C0004

    询价
  • 品牌:TargetMol
    Cell Counting Kit-8 (CCK-8) C0005

    Cell Counting Kit-8 (CCK-8) C0005

    询价
  • 品牌:TargetMol
    SYBR Green qPCR Master Mix (No ROX) C0006

    SYBR Green qPCR Master Mix (No ROX) C0006

    询价